Evidence map›Paper›PMID 29927123›Full record

ArticleCurrent protocols in nucleic acid chemistry2018

Synthesis, Characterization, and Function of an RNA-Based Transfection Reagent.

Harsh V Jain, Jessica F Boehler, Kanneboyina Nagaraju, Serge L Beaucage

Open access · greenAbstract read
In one paragraph

Article in Current protocols in nucleic acid chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Harsh V JainLaboratory of Biological Chemistry, Food and Drug Administration, Silver Spring, Maryland.
Jessica F BoehlerResearch Center for Genetic Medicine, Children's National Medical Center, Washington, District of Columbia.
Kanneboyina NagarajuResearch Center for Genetic Medicine, Children's National Medical Center, Washington, District of Columbia.
Serge L BeaucageLaboratory of Biological Chemistry, Food and Drug Administration, Silver Spring, Maryland.
United States Food and Drug Administration · USBinghamton University · USChildren's National · US

Funding

NCMRR-DC Core Molecular & Functional Outcome Measures in Rehabilitation MedicineR24HD050846 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI KNOBLACH, SUSAN M · 2005 to 2014
$8.6M
RNA fidelity and protein function of Becker-like in-frame deletionsP50AR060836 · NIAMS · CHILDREN'S RESEARCH INSTITUTE · PI PARTRIDGE, TERENCE A · 2011 to 2015
$7.8M
Wellstone Muscular Dystrophy Center: Children's Nat'l Med CtrU54HD053177 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI HOFFMAN, ERIC P. · 2005 to 2009
$7.3M
Dystrophin turnover after exon-skippingR56NS097229 · NINDS · STATE UNIVERSITY OF NY,BINGHAMTON · PI NAGARAJU, KANNEBOYINA, PARTRIDGE, TERENCE A · 2016 to 2016
$390k
Intramural FDA HHS FD999999NIAMS NIH HHS P50 AR060836NICHD NIH HHS R24 HD050846NICHD NIH HHS U54 HD053177NINDS NIH HHS R56 NS097229
6 · The paper itself

Abstract

A synthetic 8-mer, amphipathic, trans-acting poly-2'-O-methyluridylic thiophosphate triester RNA element (2'-OMeUtaPS) can be prepared using solid-phase synthesis protocols. 2'-OMeUtaPS efficiently mediates the delivery of uncharged polyA-tailed phosphorodiamidate morpholino (PMO) sequences in HeLa pLuc 705 cells, as evidenced by flow cytometry measurements. In this cell line, 2'-OMeUtaPS-mediated transfection of an antisense polyA-tailed PMO sequence induces alternative splicing of an aberrant luciferase pre-mRNA splice site, leading to restoration of functional luciferase, as quantitatively measured using a typical luciferase assay. 2'-OMeUtaPS is also potent at delivering an uncharged antisense polyA-tailed PMO sequence in muscle cells of the mdx mouse model of muscular dystrophy; targeting the polyA-tailed PMO sequence against a splice site of the pre-mRNA encoding mutated dystrophin triggers an alternate splicing event that results in excision of the mutated exon (exon 23) from the pre-mRNA and production of functional dystrophin, as demonstrated by agarose gel electrophoresis. © 2018 by John Wiley & Sons, Inc.

Indexed as

TransfectionAlternative SplicingAnimalsFlow CytometryHeLa CellsHumansIndicators and ReagentsMiceMuscular Dystrophy, AnimalOligonucleotides, AntisenseRNARNA PrecursorsIndicators and ReagentsOligonucleotides, AntisenseRNARNA Precursorscellular PMO uptakedystrophin pre-mRNAexon 23 excisionluciferase pre-mRNApre-mRNA splicing

Identifiers

PMID29927123
PMCPMC6020023
OpenAlexW2795776193

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.